We are analyzing https://link.springer.com/article/10.1007/s12026-009-8125-6.

Title:
A multi-functional role of interferon regulatory factor-8 in solid tumor and myeloid cell biology | Immunologic Research
Description:
Understanding mechanisms of tumor escape are critically important not only to improving our knowledge of cancer biology, but also for the overall development of more effective anti-neoplastic therapies. Our laboratory focuses on mechanisms of apoptotic resistance, with emphasis on Fas loss of function as an important determinant of tumor progression. Our work in solid tumor systems has led to the identification of interferon regulatory factor-8 (IRF-8) as a differentially expressed gene important for tumor cell response to cytotoxicity, including Fas-mediated apoptosis and host–anti-tumor immunosurveillance mechanisms. Although IRF-8 was originally identified in the regulation of normal and neoplastic myeloid cell development, these findings revealed a new functional role for IRF-8 in non-hematopoietic malignancies and establish a molecular basis for its potential manipulation during cancer therapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,643,078 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

article, pubmed, google, scholar, cas, cancer, tumor, cells, interferon, factor, abrams, immunol, regulatory, cell, protein, irf, expression, myeloid, consensus, liu, gene, transcription, res, response, apoptosis, suppressor, icsbp, model, carcinoma, privacy, cookies, content, research, mechanisms, escape, development, access, myeloidderived, sequence, binding, immunotherapy, immunity, oncogene, mouse, human, colon, ifn, wang, publish, search,

Topics {✒️}

host–anti-tumor immunosurveillance mechanisms protracted host-tumor interactions ifn-gamma-inducible transcription factor myeloid-derived suppressor cells tumour microenvironment anti-fas interactions influences month download article/chapter fas/fas ligand interactions death receptor-initiated apoptosis interferon regulatory factor-8 interferon regulatory factor-1 interferon-gamma induces regression effective anti-neoplastic therapies ctl adoptive immunotherapy including fas-mediated apoptosis ngf/tnf receptor superfamily icsbp transcription factors fas/fas ligand pathway optimal tumor regression myeloid cell biology tumor escape aggressive tumor variants shaping tumor immunogenicity differentiating myeloid cells tumor cell response full article pdf fas-mediated apoptosis solid tumor systems human myeloid leukemias suppressing tumor development interferon-gamma response privacy choices/manage cookies che mei lin neoplastic colon epithelium activator protein-1 elements cancer immunotherapy interferon cytokine res check access instant access related subjects chronic myelogenous leukemia myeloid cells epithelial cell carcinoma cancer biology enhanced metastatic competence transgenic mouse model rpci institutional funding solid tumor european economic area pretreatment risk features

Schema {🗺️}

WebPage:
      mainEntity:
         headline:A multi-functional role of interferon regulatory factor-8 in solid tumor and myeloid cell biology
         description:Understanding mechanisms of tumor escape are critically important not only to improving our knowledge of cancer biology, but also for the overall development of more effective anti-neoplastic therapies. Our laboratory focuses on mechanisms of apoptotic resistance, with emphasis on Fas loss of function as an important determinant of tumor progression. Our work in solid tumor systems has led to the identification of interferon regulatory factor-8 (IRF-8) as a differentially expressed gene important for tumor cell response to cytotoxicity, including Fas-mediated apoptosis and host–anti-tumor immunosurveillance mechanisms. Although IRF-8 was originally identified in the regulation of normal and neoplastic myeloid cell development, these findings revealed a new functional role for IRF-8 in non-hematopoietic malignancies and establish a molecular basis for its potential manipulation during cancer therapy.
         datePublished:2009-09-12T00:00:00Z
         dateModified:2009-09-12T00:00:00Z
         pageStart:59
         pageEnd:71
         sameAs:https://doi.org/10.1007/s12026-009-8125-6
         keywords:
            Apoptosis
            Host–tumor interactions
            Immunotherapy
            Immunosuppression
            Interferon regulatory factor-8
            Myeloid-derived suppressor cells
            Tumor escape
            Tumor immunity
            Tumor microenvironment
            Immunology
            Allergology
            Medicine/Public Health
            general
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-009-8125-6/MediaObjects/12026_2009_8125_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-009-8125-6/MediaObjects/12026_2009_8125_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-009-8125-6/MediaObjects/12026_2009_8125_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-009-8125-6/MediaObjects/12026_2009_8125_Fig4_HTML.gif
         isPartOf:
            name:Immunologic Research
            issn:
               1559-0755
               0257-277X
            volumeNumber:46
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Humana Press Inc
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Scott I. Abrams
               affiliation:
                     name:Roswell Park Cancer Institute
                     address:
                        name:Department of Immunology, Roswell Park Cancer Institute, Buffalo, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:A multi-functional role of interferon regulatory factor-8 in solid tumor and myeloid cell biology
      description:Understanding mechanisms of tumor escape are critically important not only to improving our knowledge of cancer biology, but also for the overall development of more effective anti-neoplastic therapies. Our laboratory focuses on mechanisms of apoptotic resistance, with emphasis on Fas loss of function as an important determinant of tumor progression. Our work in solid tumor systems has led to the identification of interferon regulatory factor-8 (IRF-8) as a differentially expressed gene important for tumor cell response to cytotoxicity, including Fas-mediated apoptosis and host–anti-tumor immunosurveillance mechanisms. Although IRF-8 was originally identified in the regulation of normal and neoplastic myeloid cell development, these findings revealed a new functional role for IRF-8 in non-hematopoietic malignancies and establish a molecular basis for its potential manipulation during cancer therapy.
      datePublished:2009-09-12T00:00:00Z
      dateModified:2009-09-12T00:00:00Z
      pageStart:59
      pageEnd:71
      sameAs:https://doi.org/10.1007/s12026-009-8125-6
      keywords:
         Apoptosis
         Host–tumor interactions
         Immunotherapy
         Immunosuppression
         Interferon regulatory factor-8
         Myeloid-derived suppressor cells
         Tumor escape
         Tumor immunity
         Tumor microenvironment
         Immunology
         Allergology
         Medicine/Public Health
         general
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-009-8125-6/MediaObjects/12026_2009_8125_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-009-8125-6/MediaObjects/12026_2009_8125_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-009-8125-6/MediaObjects/12026_2009_8125_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-009-8125-6/MediaObjects/12026_2009_8125_Fig4_HTML.gif
      isPartOf:
         name:Immunologic Research
         issn:
            1559-0755
            0257-277X
         volumeNumber:46
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Humana Press Inc
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Scott I. Abrams
            affiliation:
                  name:Roswell Park Cancer Institute
                  address:
                     name:Department of Immunology, Roswell Park Cancer Institute, Buffalo, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Immunologic Research
      issn:
         1559-0755
         0257-277X
      volumeNumber:46
Organization:
      name:Humana Press Inc
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Roswell Park Cancer Institute
      address:
         name:Department of Immunology, Roswell Park Cancer Institute, Buffalo, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Scott I. Abrams
      affiliation:
            name:Roswell Park Cancer Institute
            address:
               name:Department of Immunology, Roswell Park Cancer Institute, Buffalo, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Immunology, Roswell Park Cancer Institute, Buffalo, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(135)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.27s.

LINK . SPRINGER . COM {}